Navigation Links
Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
Date:11/14/2007

CORAL GABLES, Fla., Nov. 14 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today reported financial results for the quarter ended September 30, 2007.

Third Quarter 2007 Results

For the quarter ended September 30, 2007, the Company reported a net loss of $734,347 or $0.06 loss per basic and diluted share, compared to a net loss of $1,321,388, or $0.19 loss per basic and diluted share for the same period in 2006. Third quarter 2007 results were impacted by non-cash charges relating to stock-based compensation in the amount of $94,482, compared to $828,818 in the same period in 2006. For the nine months ended September 30, 2007, the Company reported a net loss of $3,194,555, or $0.26 loss per basic and diluted share, compared to a net loss of $1,988,213, or $0.29 loss per basic and diluted share for the same period in 2006. Results for the first nine months of 2007 were impacted by non-cash charges relating to stock-based compensation in the amount of $477,083, compared to $1,069,943 in the same period in 2006.

Research and development expenses for the third quarter of 2007 were $503,348, an increase of 113.8% compared to $235,467 in the third quarter of 2006. These include non-cash stock-based compensation of $75,997 and $88,993, respectively. Research and development expenses for the nine months ended September 30, 2007 were $2,268,648, an increase of 239.5% compared to $668,231 for the first nine months of 2006. These include non-cash stock-based compensation of $315,710 and $302,368, respectively.

General and administrative expenses for the third quarter of 2007 totaled $447,078, a decrease of 59.6% compared to $1,106,752 in the third quarter of 2006. These inc
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
10. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
11. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 Let’s not lose focus of ... are today’s traffic magnets. Three out of 4 consumers ... their produce department, according to a Packaged Facts survey. ... are looking to add more fruits and vegetables to ... Day is April 2. As featured in the Chase’s ...
(Date:3/26/2015)... North American Seminars launches it new mobile ... providing information regarding OT PT continuing education courses to ... a leader in live hands PT continuing education ... and online continuing education courses. , Featured ... Master Clinicians Approach to Advanced Concepts in Examination and ...
(Date:3/26/2015)... 26, 2015 Florida Hospital teamed up with ... Your Health campaign and live Dr. Oz event, which took ... 21st. More than a thousand people came out to see ... , The world renowned cardiothoracic surgeon and Emmy award ... Hurtado and a panel of experts for the live health ...
(Date:3/26/2015)... March 26, 2015 The Baruch S. ... team of nationally renowned scientists to focus exclusively on ... move that nearly triples its research capacity and has ... on hepatitis B and liver cancer in the United ... Jinhong Chang, Ju Tao Guo and Ying-Hsiu Su – ...
(Date:3/26/2015)... March 26, 2015 “The SWEET Act is ... healthy options more available and help parents who are working ... is a reasonable approach to support public health, and we ... issue for the health of all families,” said Dr. Jane ... Health on the introduction of the Sugar-Sweetened Beverage Tax (SWEET) ...
Breaking Medicine News(10 mins):Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2
... give back to Mercy Ships , ... Garden Valley. TX (Vocus) August ... greatest medal hopes at the Beijing Olympics, racer Paul Goodison, has announced ... medical care to the people of Africa. , , , , ,While ...
... service now available for pet owners and first responders in the ... pet safety company in the Northern Hemisphere, Rover Respond,R™ not only ... and animal rescue groups and provides peace of mind to pet ... ...
... rapid growth in popularity of DNA testing and genetic profiling is ... benefits available from genetic tests outweigh consumers, privacy concerns. From ... testing data to drive health and lifestyle decisions is gaining acceptance. ... ...
... ARE OBESE MAY CARRY ASTHMA TRAIT , A new ... may carry a specific trait or phenotype that causes ... are not obese with asthma. Researchers from Quebec, Canada ... cell counts, symptom perceptions, BMI/waist circumference, and waist-to-hip ratio ...
... ANN ARBOR, Mich., Aug. 4 The Kansas Health ... data system that,will enable the agency to analyze the ... system -- comprised of a data repository and a ... care data for several,state programs. Andy Allison, KHPA,s deputy ...
... nanotechnology, scientists already know that size does matter. , But ... Hill have shown that shape matters even more a ... for treating cancer and other diseases, from diabetes and multiple ... led by Joseph DeSimone, Ph.D., Chancellor,s Eminent Professor of Chemistry ...
Cached Medicine News:Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 2Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 3Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 4Health News:Emergencies Are No Longer Obstacles in Responsible Pet Care 2Health News:Emergencies Are No Longer Obstacles in Responsible Pet Care 3Health News:DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal 2Health News:DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal 3Health News:Chest Journal: August news briefs 2Health News:Kansas Health Policy Authority Awards Thomson Reuters Contract for Health Care Data Integration and Analysis Initiative 2Health News:Kansas Health Policy Authority Awards Thomson Reuters Contract for Health Care Data Integration and Analysis Initiative 3Health News:UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies 2Health News:UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies 3
(Date:3/26/2015)... SAN ANTONIO and STAEFA, Switzerland ... based on the Venture platform, wirelessly transmits sound from the ... better hearing ear. This allows people with single-sided deafness to ... before. The new fitting process for Phonak CROS II is ... users can instantly experience the benefits of the CROS solution ...
(Date:3/26/2015)... , March 26, 2015  Becton, Dickinson and ... it will commence offers to exchange all validly tendered ... CareFusion Corporation, a wholly owned subsidiary of BD, for ... the table below. A Registration Statement on Form S-4 ... New Notes was filed with the Securities and Exchange ...
(Date:3/26/2015)... 26, 2015  Oxis Biotech, Inc. (OXIS), ... Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] ... option agreement with the University of Pittsburgh ... Dr. Xiang-Qun Xie , Associate Dean ... School of Pharmacy.  These patents/intellectual properties relate ...
Breaking Medicine Technology:Phonak CROS II: The smart solution for single-sided deafness 2Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3
... DALLAS, Aug. 3 ACCESS PHARMACEUTICALS, INC. ... update today on its clinical development strategy for ProLindac , ... be active in many solid tumors in human clinical studies. Access has ... dose levels and regimens of ProLindac monotherapy in cancer patients, provide additional data ...
... Grammy-Award winning artist and long-time (PRODUCT)RED supporter John Legend ... for his August 13th, 2009 concert at Madison Square Garden in ... Gap stores in the New York tri-state area will include a ... reserved RED(ZONE) section for John Legend,s MSG show. Even better, with ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 3Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 2John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden 3
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Digoxin in human serum....
For the quantitative in vitro determination of Microalbumin in urine....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Medicine Products: